Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
With markets choppy and traditional bonds offering limited growth, the JEPI ETF is drawing attention as a way to gene...
A cheap-fee tech ETF hides a big concentration in three megacaps. When paired with broad-market funds, investors risk...
A $1 million retirement target yields about $40,000 a year under the 4% rule, but inflation and healthcare costs wide...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
Investors eye a single ETF as the simplest path for the rest of 2026 amid AI-driven gains and shifting rate expectati...
A blockchain-focused stock fund is up about 11% year-to-date while Bitcoin slides about 29%, signaling a shift in how...
An ESG equity fund has posted a double-digit gain while steering clear of Meta. Its AI-forward lineup centers on Alph...
As rates linger and real estate cycles shift, investors weigh VNQ and SCHH for income. This report compares yields, s...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
A 65-year-old retiree with $1.9 million faces a shrinking sustainable income due to a conservative mix. The case high...